Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 8 min 53 sec ago

Innovus Pharma Expands Management Team and Adds Chief Financial Officer

Tue, 02/11/2014 - 12:47
Lynnette Dillen Brings 20 Years' Experience in Finance, Accounting LA JOLLA, Calif., Feb. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (INNV), today announced tha...
Biopharmaceuticals, Personnel
Innovus Pharmaceuticals

Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller

Tue, 02/11/2014 - 12:43
LOS ANGELES, Feb. 11, 2014 -- (Healthcare Sales & Marketing Network) -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™ eTNS™ System for the treatment of neurological and ne...
Devices, Neurology, Personnel
NeuroSigma, Monarch, eTNS System

AliveCor Receives FDA Over-the-Counter Clearance for Its Heart Monitor

Mon, 02/10/2014 - 16:00
Provides an easier way for individuals to participate in their heart health SAN FRANCISCO--(Healthcare Sales & Marketing Network)--AliveCor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted the company over-the-counter (...
Devices, Cardiology, Monitoring, FDA, Product Launch
AliveCor, Heart Monitor, ECG

ACell Launches New MatriStem(R) Multilayer Wound Matrix Device

Mon, 02/10/2014 - 15:52
Solution for deep, hard-to-heal wounds with additional contouring functionality COLUMBIA, Md., Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and...
Devices, Regenerative Medicine, Wound Care, Product Launch
ACell , MatriStem, Multilayer Wound Matrix

Smiths Medical Launches MR Conditional Wire-reinforced Silicone Tracheostomy Tubes for Neonates and Pediatric Patients

Mon, 02/10/2014 - 15:47
Company introduces standard version of Bivona FlexTend™ TTS™ cuffed tracheostomy tubes for children in healthcare and homecare settings ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--Smiths Medical, a leading global medical device manufacture...
Devices, Product Launch
Smiths Medical, Bivona FlexTend, tracheostomy tube

Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.

Mon, 02/10/2014 - 13:35
All-stock transaction Conference call to discuss pending acquisition today at 8:30am Eastern Time SAN DIEGO, Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that it has entered into...
Biopharmaceuticals, Mergers & Acquisitions
Mast Therapeutics, Aires Pharmaceuticals

Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision

Mon, 02/10/2014 - 13:29
TARRYTOWN, N.Y., Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in the Phase 3 VISTA-DME trial of EYLEA® (aflibercept) Injection for the treatment of ...
Biopharmaceuticals, Ophthalmology
Regeneron Pharmaceuticals, Bayer HealthCare, EYLEA, aflibercept, VISTA-DME

Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data

Mon, 02/10/2014 - 13:18
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2014 -- (Healthcare Sales & Marketing Network) -- Sunesis Pharmaceuticals, Inc. (SNSS) today announced the appointment of Joseph I. DePinto to the newly created position of Executive Vice President and Chief Commercial...
Biopharmaceuticals, Oncology, Personnel
Sunesis Pharmaceuticals, Vosaroxin

Alliqua Appoints Janice M. Smiell, M.D. as its First Chief Medical Officer

Mon, 02/10/2014 - 13:14
Extensive Wound Care Experience Adds Strength to Management Team LANGHORNE, Pa.--(Healthcare Sales & Marketing Network)--Alliqua, Inc. (ALQA) (“Alliqua” or “the Company”) has appointed Janice M. Smiell, M.D. as its Chief Medical Officer, a newly created...
Devices, Wound Care, Personnel
Alliqua, SilverSeal

New Breast Cancer Surgical Guidelines Can Reduce Unnecessary Procedures and Patient Costs

Mon, 02/10/2014 - 13:08
Guidelines Result from Susan G. Komen Funding of Medical Consortium that Included Leading Practitioners and Komen Patient Advocate DALLAS--(Healthcare Sales & Marketing Network)--New surgical guidelines announced today by the Society of Surgical Oncolog...
Oncology, Surgery
Susan G. Komen, breast cancer

SciClone Appoints Charles Meng as General Counsel and Vice President of Compliance

Mon, 02/10/2014 - 13:01
FOSTER CITY, CA--(Healthcare Sales & Marketing Network) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the appointment of Charles Meng as General Counsel and Vice President of Compliance effective February 9, 2014. Mr. Meng has more than ...
Biopharmaceuticals, Personnel
SciClone Pharmaceuticals, ZADAXIN, thymalfasin, hepatitis B

Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development

Fri, 02/07/2014 - 16:01
FRANKLIN LAKES, N.J., Feb. 7, 2014 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading global technology company, today announced the appointment of Amit Bhalla as Vice President, Global Strategy and Developmen...
Devices, Personnel
BD , Amit Bhalla

Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure

Fri, 02/07/2014 - 15:57
CARY, N.C., Feb. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Covis Pharmaceuticals today announced that LANOXIN® is now offered in four dosage strengths, including the new 0.0625mg and 0.1875mg strengths, for the treatment of mild-to-moderate...
Biopharmaceuticals, Cardiology
Covis Pharmaceuticals, LANOXIN, Digoxin, heart failure

BRCA Patent Owners and Gene by Gene, Ltd. Resolve Patent Suit

Fri, 02/07/2014 - 12:59
HOUSTON and SALT LAKE CITY, Feb. 7, 2014 -- (Healthcare Sales & Marketing Network) -- Gene by Gene, Ltd. and Myriad Genetics, Inc., the University of Utah Research Foundation, HSC Research and Development Limited Partnership, Endorecherche, Inc., and the T...
Diagnostics, Oncology, Litigation
Myriad Genetics, Gene by Gene, BRCA testing, BRCA1, BRCA2

Ipsen announces positive top line results from phase III clinical study of Decapeptyl(R) (triptorelin pamoate) 11.25 mg administered subcutaneously in patients with prostate cancer

Fri, 02/07/2014 - 12:51
Efficacy and safety results from phase III study of triptorelin pamoate 11.25 mg administered subcutaneously are both clinically and statistically significant These results are consistent with the known efficacy and safety profile of Decapeptyl® whe...
Biopharmaceuticals, Oncology
Ipsen, Decapeptyl, triptorelin pamoate, prostate cancer

Medtronic Introduces New Generation Enlite Sensor for People with Diabetes Across Western Europe

Thu, 02/06/2014 - 17:09
Latest Continuous Glucose Monitoring Sensor Provides Improved Comfort and Sensing Experience VIENNA -- February 6, 2014 -- (Healthcare Sales & Marketing Network) -- Medtronic, Inc. (NYSE:MDT) today announced the European launch of new generation Enlite...
Devices, Monitoring, Endocrinology, Product Launch
Medtronic, Enlite glucose sensor, glucose monitor, diabetes

Ultragenyx Appoints Clay Siegall, Ph.D. and Matthew Fust to Board of Directors

Thu, 02/06/2014 - 15:43
NOVATO, Calif., Feb. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the appointment of C...
Biopharmaceuticals, Personnel

Pathway Genomics Names Ardy Arianpour as Chief Strategy Officer

Thu, 02/06/2014 - 13:14
SAN DIEGO--(Healthcare Sales & Marketing Network)--Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services worldwide, today announced it has appointed Ardy Arianpour, MBA, as chief st...
Diagnostics, Personalized Medicine, Personnel
Pathway Genomics

Covidien Receives U.S. FDA 510(k) Clearance for Reinforced Stapling Reload Technology

Thu, 02/06/2014 - 13:08
Endo GIA™ Reinforced Reload with Tri-Staple™ technology integrates tissue reinforcement buttressing capability with surgical stapling device DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc. (COV) announced that the U.S. Food and Dr...
Devices, Surgery, FDA
Covidien, Endo GIA, Reinforced Reload, Tri-Staple, surgical stapler

St. Jude Medical Announces First US Patient Implant of Non-Surgical, Leadless Cardiac Pacemaker

Thu, 02/06/2014 - 13:01
Commencement of LEADLESS II clinical research trial represents important milestone in bringing transformational pacing technology to U.S. patients ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical de...
Devices, Cardiology
St. Jude Medical, Nanostim, leadless pacemaker, LEADLESS II

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong